Only in Titles

           Search results for: Annexin V Unlabeled Reagent5 mg   

paperclip

#28881632   // Save this To Up

Preliminary biological evaluation ofF-AlF-NOTA-MAL-Cys-Annexin V as a novel apoptosis imaging agent.

A novel annexin V derivative (Cys-Annexin V) with a single cysteine residue at its C-terminal has been successfully labeled site-specifically with NOTA-maleimide aluminum [F]fluoride complexation and evaluated it as a novel apoptosis agentand. The total synthesis time ofF-AlF-NOTA-MAL-Cys-Annexin V from [F]fluoride was about 65 min. The tracer was stableand it was excreted through renal in normal mice. The rate of the tracer bound to erythrocytes with exposed phosphatidylserine was 89.36±0.61% and this binding could be blocked by unlabeled Cys-Annexin V. In rats treated with cycloheximide, there were 6.23±0.23 times (n=4) increase in hepatic uptake of the tracer as compared to normal rats at 1h p.i. The uptake of the tracer in liver also could be blocked by co-injection of unlabeled Cys-Annexin V. These results indicated the favorable characterizations such as convenient synthesis and specific apoptotic cells targeting ofF-AlF-NOTA-MAL- Cys-Annexin V were suitable for its further investigation in clinical apoptosis imaging.

2272 related Products with: Preliminary biological evaluation ofF-AlF-NOTA-MAL-Cys-Annexin V as a novel apoptosis imaging agent.

Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Annexin V FITC Apoptosis Annexin V FITC Apoptosis Annexin V Cy3 Apoptosis K Annexin V Cy3 Apoptosis K Annexin V Cy5 Apoptosis K

Related Pathways

paperclip

#26837335   // Save this To Up

Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin.

Noninvasive imaging of cell death can provide an early indication of the efficacy of tumor treatment, aiding clinicians in distinguishing responding patients from nonresponding patients early on. (99m)Tc-duramycin is a SPECT tracer for cell death imaging. In this study, our aim was to validate the use of (99m)Tc-duramycin for imaging the early response of tumors to treatment.

1321 related Products with: Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin.

Rat TGF-beta-inducible ea Rat TGF-beta-inducible ea FDA Standard Frozen Tissu FDA Standard Frozen Tissu FDA Standard Frozen Tissu FDA Standard Frozen Tissu Ofloxacin CAS Number [824 Tonsil disease spectrum ( Total Protein Human Tumor Total RNA - Human Tumor T Topoisomerase II; Clone Topoisomerase II; Clone

Related Pathways

paperclip

#23485626   // Save this To Up

DiI labeling of human adipose-derived stem cells: evaluation of DNA damage, toxicity and functional impairment.

Adipose tissue-derived stem cells (ASCs) have become the primary focus of tissue engineering research. To understand their functions and behavior in in vitro and in vivo models, it is mandatory to track the implanted cells and distinguish them from the resident or host cells. A common labeling method is the use of fluorescent dyes, e.g. the lipophilic carbocyanine dye, DiI. This study aimed to analyze potential DNA damage, toxicity and impairment of the functional properties of human ASCs after labeling with DiI.

1554 related Products with: DiI labeling of human adipose-derived stem cells: evaluation of DNA damage, toxicity and functional impairment.

Macrophage Colony Stimula Macrophage Colony Stimula Human Cord Blood CD34+ Ce Stemez hN2 Human Neuron D AccuPrep Genomic DNA Extr LumiSTEM 96 iPS MSC deriv Anti C Reactive Protein A Epidermal Growth Factor ( Epidermal Growth Factor ( Human Brain Derived Neuro Human Glial Derived Neuro Human Stem Cell Factor SC

Related Pathways

paperclip

#22392643   // Save this To Up

Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.

This study aims to apply longitudinal positron emission tomography (PET) imaging with (18)F-Annexin V to visualize and evaluate cell death induced by doxorubicin in a human head and neck squamous cell cancer UM-SCC-22B tumor xenograft model.

1100 related Products with: Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.

Jurkat Cell Extract (Indu Jurkat Cell Extract (Indu Jurkat Cell Extract (Indu Jurkat Cell Extract (Indu Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Cell Meter™ Annexin V B Rabbit Anti-Cell death in

Related Pathways

paperclip

#21918686   // Save this To Up

Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissue.

Renal ischemia/reperfusion injury (IRI) frequently complicates shock, renal transplantation and cardiac and aortic surgery, and has prognostic significance. The translocation of phosphatidylserines to cell surfaces is an important pro-inflammatory signal for cell-stress after IRI. We hypothesized that shielding of exposed phosphatidylserines by the annexin A5 (ANXA5) homodimer Diannexin protects against renal IRI. Protective effects of Diannexin on the kidney were studied in a mouse model of mild renal IRI. Diannexin treatment before renal IRI decreased proximal tubule damage and leukocyte influx, decreased transcription and expression of renal injury markers Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 and improved renal function. A mouse model of ischemic hind limb exercise was used to assess Diannexin biodistribution and targeting. When comparing its biodistribution and elimination to ANXA5, Diannexin was found to have a distinct distribution pattern and longer blood half-life. Diannexin targeted specifically to the ischemic muscle and its affinity exceeded that of ANXA5. Targeting of both proteins was inhibited by pre-treatment with unlabeled ANXA5, suggesting that Diannexin targets specifically to ischemic tissues via phosphatidylserine-binding. This study emphasizes the importance of phosphatidylserine translocation in the pathophysiology of IRI. We show for the first time that Diannexin protects against renal IRI, making it a promising therapeutic tool to prevent IRI in a clinical setting. Our results indicate that Diannexin is a potential new imaging agent for the study of phosphatidylserine-exposing organs in vivo.

2800 related Products with: Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissue.

Renal disease spectrum ti Kidney cancer test tissue Incu Tissue(square vessel Incu Tissue(square vessel Incu Tissue(square vessel T-2 Toxin Mycotoxins ELIS Zearalenone Mycotoxins EL Multi organ carcinoma tis Multi organ carcinoma tis Top five cancer tissue ar Pancreatic carcinoma and Multiple organs tumor and

Related Pathways

paperclip

#21220490   // Save this To Up

Cell-penetrating TAT-FOXO3 fusion proteins induce apoptotic cell death in leukemic cells.

FOXO proteins are Akt-regulated transcription factors involved in the control of cell cycle, DNA repair, stress defense, apoptosis, and tumor suppression. We reported that plasmid-based overexpression of constitutively active FOXO3 in cells from chronic lymphocytic leukemia (CLL) reduced their survival, suggesting that increasing FOXO3 activity in hematologic malignancies may represent a promising therapeutic strategy. The transactivating transcription factor (TAT) protein transduction domain (PTD) derived from the HIV TAT protein was shown to efficiently deliver macromolecular cargo in various cell types. In this study, wild-type FOXO3 and FOXO3 mutated on Akt sites [FOXO3 T32A/S253A/S315A or TM (triple mutant)] were fused to the TAT-PTD. Using biochemical techniques, flow cytometry, and microscopy analysis, we found a rapid and dose-dependent cell penetration into leukemic cells of unlabeled and fluorescein isothiocyanate-labeled TAT-FOXO3 fusion proteins followed by their accumulation within nuclear and cytoplasmic compartments. Treatment with TAT-FOXO3 TM-but not wild-type TAT-FOXO3-proteins induced Jurkat and K562 leukemic cell death and affected cell viability of other hematologic malignancies including primary cells from CLL. Cell transduction with TAT-FOXO3 TM induced apoptotic cell death as shown by morphologic changes, Annexin V/7-AAD (7-amino-actinomycin D) staining, activation of effector caspases, and PARP cleavage, caspase blockade through the use of the inhibitor Z-VAD, and expression of Bim and p27(KIP1). By contrast, TAT-FOXO3 TM blocked cell proliferation of primary T cells, without affecting their viability. Together, our data show that cell penetrating TAT-FOXO3 TM fusion proteins constitute novel potential therapeutic agents in the treatment of lymphoproliferative disorders and hematologic malignancies.

1468 related Products with: Cell-penetrating TAT-FOXO3 fusion proteins induce apoptotic cell death in leukemic cells.

Jurkat Cell Extract (Indu Jurkat Cell Extract (Indu Jurkat Cell Extract (Indu Jurkat Cell Extract (Indu Rabbit Anti-Cell death in Rabbit Anti-Cell death in Rabbit Anti-Cell death in Rabbit Anti-Cell death in Rabbit Anti-Cell death in Rabbit Anti-Cell death in Rabbit Anti-Cell death in Rabbit Anti-Cell death in

Related Pathways

paperclip

#20124049   // Save this To Up

Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging.

Ischemic insult to the myocardium is associated with cardiomyocyte apoptosis. Because apoptotic cell death is characterized by phosphatidylserine externalization on cell membrane and annexin-A5 (AA5) avidly binds to phosphatidylserine, we hypothesized that radiolabeled AA5 should be able to identify the regions of myocardial ischemia.

1202 related Products with: Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging.

Goat Anti- Homeobox A5, ( Eosin 5 isothiocyanate, R Ofloxacin CAS Number [824 Purified Rabbit Anti Huma Purified Rabbit Anti Huma Annexin A5 Annexin A5 Antibody Interleukin-34 IL34 (N-t Interleukin-34 IL34 anti PolyTek HRP Anti-Rabbit PolyTek HRP Anti-Mouse P Sterile filtered goat se

Related Pathways

paperclip

#19769945   // Save this To Up

Withaferin A targets heat shock protein 90 in pancreatic cancer cells.

The purpose of this study is to investigate the efficacy and the mechanism of Hsp90 inhibition of Withaferin A (WA), a steroidal lactone occurring in Withania somnifera, in pancreatic cancer in vitro and in vivo. Withaferin A exhibited potent antiproliferative activity against pancreatic cancer cells in vitro (with IC(50)s of 1.24, 2.93 and 2.78 microM) in pancreatic cancer cell lines Panc-1, MiaPaCa2 and BxPc3, respectively. Annexin V staining showed that WA induced significant apoptosis in Panc-1 cells in a dose-dependent manner. Western blotting demonstrated that WA inhibited Hsp90 chaperone activity to induce degradation of Hsp90 client proteins (Akt, Cdk4 and glucocorticoid receptor), which was reversed by the proteasomal inhibitor, MG132. WA-biotin pull down assay of Hsp90 using Panc-1 cancer cell lysates and purified Hsp90 showed that WA-biotin binds to C-terminus of Hsp90 which was competitively blocked by unlabeled WA. Co-immunoprecipitation exhibited that WA (10 microM) disrupted Hsp90-Cdc37 complexes from 1 to 24h post-treatment, while it neither blocked ATP binding to Hsp90, nor changed Hsp90-P23 association. WA (3, 6mg/kg) inhibited tumor growth in pancreatic Panc-1 xenografts by 30% and 58%, respectively. These data demonstrate that Withaferin A binds Hsp90, inhibits Hsp90 chaperone activity through an ATP-independent mechanism, results in Hsp90 client protein degradation, and exhibits in vivo anticancer activity against pancreatic cancer.

2116 related Products with: Withaferin A targets heat shock protein 90 in pancreatic cancer cells.

Rabbit heat shock protein Rabbit heat shock protein Glucagon ELISA KIT, Rat G Heat Shock Protein 90, hu HSP90C | alfa HSP90C, hea Mouse Anti-Heat Shock Pro Anti-Infectious Pancreati Anti-Infectious Pancreati Anti-Infectious Pancreati Mouse Anti-Heat Shock Pro Mouse Anti-Heat Shock Pro Mid advanced stage pancre

Related Pathways

paperclip

#16735183   // Save this To Up

In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood.

The aim of this study was to label human umbilical cord blood mesenchymal stem cells (MSCs) with poly-l-lysine (PLL)-conjugated superparamagnetic iron oxide particles and to obtain magnetic resonance (MR) images of the labeled MSCs' suspension at 1.5 T.

1091 related Products with: In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood.

Macrophage Colony Stimula Macrophage Colony Stimula Human Cord Blood CD34+ Ce anti H inh human blood an Anti beta3 AR Human, Poly Human integrin aVb3, affi Human Umbilical Vein Endo GFP Expressing Human Umbi Mitochondria GFP Tag Huma Plasma Membrane GFP Tag H RFP Expressing Human Umbi Human Small Intestine Mic

Related Pathways

  •  
  • No related Items
paperclip

#16241952   // Save this To Up

Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex.

Binding of fluorescein-labeled coagulation factors IXa, VIII, X, and allophycocyanin-labeled annexin V to thrombin-activated platelets was studied using flow cytometry. Upon activation, two platelet subpopulations were detected, which differed by 1-2 orders of magnitude in the binding of the coagulation factors and by 2-3 orders of magnitude in the binding of annexin V. The percentage of the high-binding platelets increased dose dependently of thrombin concentration. At 100 nm of thrombin, platelets with elevated binding capability constituted approximately 4% of total platelets and were responsible for the binding of approximately 50% of the total bound factor. Binding of factors to the high-binding subpopulation was calcium-dependent and specific as evidenced by experiments in the presence of excess unlabeled factor. The percentage of the high-binding platelets was not affected by echistatin, a potent aggregation inhibitor, confirming that the high-binding platelets were not platelet aggregates. Despite the difference in the coagulation factors binding, the subpopulations were indistinguishable by the expression of general platelet marker CD42b and activation markers PAC1 (an epitope of glycoprotein IIb/IIIa) and CD62P (P-selectin). Dual-labeling binding studies involving coagulation factors (IXa, VIII, or X) and annexin V demonstrated that the high-binding platelet subpopulation was identical for all coagulation factors and for annexin V. The high-binding subpopulation had lower mean forward and side scatters compared with the low-binding subpopulation ( approximately 80% and approximately 60%, respectively). In its turn, the high-binding subpopulation was not homogeneous and included two subpopulations with different scatter values. We conclude that activation by thrombin induces the formation of two distinct subpopulations of platelets different in their binding of the components of the intrinsic fX-activating complex, which may have certain physiological or pathological significance.

1521 related Products with: Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex.

Anti AGO2 Human, Monoclon Anti AGO2 Mouse, Monoclon Anti AGO2 Human, Monoclon Anti AGO2 Mouse, Monoclon Macrophage Colony Stimula Macrophage Colony Stimula Recombinant Human Intrins Recombinant Human Intrins Recombinant Human Intrins Thermal Shaker with cooli Native Pig Intrinsic Fact FDA Standard Frozen Tissu

Related Pathways